课题基金 / 基金详情

Molecular biological studies on the roles of NFkappaBETA and NF-IL6 in the experimental glomerulonephritis and diabetic nephropathy.

Molecular biological studies on the roles of NFkappaBETA and NF-IL6 in the experimental glomerulonephritis and diabetic nephropathy.
NFkappaBETA和NF-IL6在实验性肾小球肾炎和糖尿病肾病中作用的分子生物学研究。
批准号:
08457289
负责人:
HAYASHI Matsuhiko
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

HAYASHI Matsuhiko的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To reveal the effcnts of cytokines on the cultured mesangial cells, we examined the interactions between endothelin, IL-1beta, TNF-alpha, and lipopolysaccharide. It was shown that endothelin suppress the induction of NO synthase by these cytokines, which are known to exert their action via NFkappaBETA. We have also made a vector, which has 6 NFkappaBETA binding cite in the upstream of luciferase, and transfected it to mesangial cells. In these transfected cells, angiotensin II induced 6-fold increase in luciferase activity, suggesting that angiotensin II activates NFkappaBETA. From these results, it was suggested that NFkappaBETA plays an important role in the effects of cytokines on mesangial cells, next we made mutated IkappaBETA. This IkappaBETA lacks phosphorilation cite, which is necessary for the atctivation of NFkappaBETA. Therefore, the overexpression of mutated IkappaBETA should abolish the effects of cytokines. In the mesangial cells with the adenovirus-mediated transfection of mutated IkappaBETA, TNF-alpha showed enhanced induction of apoptosis, compared with wild type cells. It was also shown that induction of apoptosis was enhanced with the transfection of mutated IkappaBETA by IL-1 and lipopolysaccharides. From these results, it was shown that NFkappaBETA was a suppressor of apoptosis. Next, we tried to infect the adenovirus to the kidneys for the transfection of mutated IkappaBETA, although the injected adenovirus to the renal artery infected to only proximal tubules. Currently, we are developing a technique for the in vivo transfer of the mutated IkappaBETA to the kidney.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Sasamura H,et al.: "Regulation of vascular type 1 angiotensin receptors by cyokines." Hypertension. 30[part 1]. 35-41 (1997)
Sasamura H 等人:“细胞因子对血管 1 型血管紧张素受体的调节”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hirahashi J,et al.: "Endothelin-1 inhibits induction of nitric oxide synthase and CTP cyclohydrolase-I in rat mesangial cells" Pharmacology. 53(4). 241-249 (1966)
Hirahashi J 等人:“Endothelin-1 抑制大鼠系膜细胞中一氧化氮合酶和 CTP 环水解酶-I 的诱导”药理学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sasamura H,et al.: "Regulation of vascular type 1 angiotensin receptors by cytokines" Hypertension. 30(1). 35-41 (1997)
Sasamura H 等人:“细胞因子对血管 1 型血管紧张素受体的调节”高血压。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hirahashi J, et al.: "Endothelin-1 inhibits induction of nitirc oxide synthase and GTP cyclohydrolase I in rat mesangiasl cells." Pharmacology. 53. 241-249 (1996)
Hirahashi J 等人:“Endothelin-1 抑制大鼠系膜细胞中一氧化氮合酶和 GTP 环水解酶 I 的诱导。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    The studies on the roles of transcriptional factors in pathogenesis of vascular calcification by chronic kidney disease and their application for the therapy
    • 批准号:
      23591200
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      HAYASHI Matsuhiko
    • 依托单位:
    The study on the molecular relationships between TRPC6, NFκB, and NFAT in the progress of chronic kidney diseases
    • 批准号:
      20590961
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      HAYASHI Matsuhiko
    • 依托单位:
    Study on cell-specific roles of nudear factor KB in the progression of renal diseases with genetically modified animals
    • 批准号:
      18590903
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.6万
    • 财政年份:
      2006
    • 负责人:
      HAYASHI Matsuhiko
    • 依托单位:
    Identification of target molecule for the treatment of progressive renal diseases and its application for gene therapy.
    • 批准号:
      15590859
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      2003
    • 负责人:
      HAYASHI Matsuhiko
    • 依托单位: